The intricate world of drug discovery relies heavily on specialized chemical building blocks, and 6-Iodoquinazolin-4-one (CAS: 16064-08-7) is a prime example. This heterocyclic compound serves as a crucial intermediate, offering researchers a versatile platform for synthesizing novel therapeutic agents. Its unique chemical structure, featuring an iodine atom and a quinazolinone core, allows for diverse functionalization, paving the way for new drug candidates.

Scientists engaged in organic synthesis often utilize 6-Iodoquinazolin-4-one due to its reactivity and established synthetic routes. Common methods involve reactions that build upon its core structure, leading to more complex molecules with potential biological activity. As a supplier of research chemicals, we provide high-purity 6-Iodoquinazolin-4-one, ensuring that laboratory investigations yield accurate and reproducible results.

The significance of 6-Iodoquinazolin-4-one extends to its role in creating compounds with potential anticancer, antimicrobial, or other pharmacological properties. For R&D scientists, securing a reliable source for this compound is key. We understand the demands of the research community and are committed to being a dependable 6-Iodoquinazolin-4-one manufacturer, offering consistent quality for your critical experiments. You can inquire about our product price for research quantities.

When exploring the application of this compound, it's important to consider its purity and stability. Our product specifications, including its appearance as a white to off-white solid and its purity exceeding 98%, are designed to meet the rigorous demands of drug discovery laboratories. We aim to support innovation by providing essential chemical intermediates.

For laboratories seeking to purchase 6-Iodoquinazolin-4-one for their next breakthrough, partnering with a reputable chemical supplier is essential. We pride ourselves on being a trusted source for R&D materials, offering excellent support to scientists advancing the frontiers of medicine.